Evidence map›Paper›PMID 37493974›Full record

ArticleBlood advances2023

Acquisition of a glycosylated B-cell receptor drives follicular lymphoma toward a dark zone phenotype.

Cornelis A M van Bergen, Susan L Kloet, Edwin Quinten, Julieta H Sepúlveda Yáñez, Roberta Menafra, Marieke Griffioen, Patty M Jansen, Marvyn T Koning, Jeroen Knijnenburg, Marcelo A Navarrete and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cornelis A M van BergenDepartment of Hematology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-6386-4517
Susan L KloetLeiden Genome Technology Center, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-9189-0640
Edwin QuintenDepartment of Hematology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-9470-9683
Julieta H Sepúlveda YáñezDepartment of Hematology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-6354-3609
Roberta MenafraLeiden Genome Technology Center, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-5266-0639
Marieke GriffioenDepartment of Hematology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-3001-4441
Patty M JansenDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Marvyn T KoningDepartment of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
Jeroen KnijnenburgDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-5662-7054
Marcelo A NavarreteEscuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile.ORCID 0000-0002-2044-9548
Szymon M KiełbasaDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0003-2805-6535
Hendrik VeelkenDepartment of Hematology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-9108-3125

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37493974
PMCPMC10561043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.